Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

mSystems, 2023
Abnormal blood microbiota profiles are associated with inflammation and immune restoration in HIV/AIDS individuals

Guo X., Wang Z., Qu M. et al.

Olink Target 96Infectious DiseasesPathophysiologyPlasma

Open Forum Infectious Diseases, 2023
Biological and Clinical Implications of the Vascular Endothelial Growth Factor Coreceptor Neuropilin-1 in Human Immunodeficiency Virus

Schnittman S., Kolossváry M., Beck-Engeser G. et al.

Olink Target 96CVDInfectious DiseasesPathophysiologyPlasma

BMC Medicine, 2023
Integrated unbiased multiomics defines disease-independent placental clusters in common obstetrical syndromes

Barak O., Lovelace T., Piekos S. et al.

Olink Target 96ObstetricsPatient StratificationData ScienceTissue Lysate

Translational Neurodegeneration, 2023
Large-scale proximity extension assay reveals CSF midkine and DOPA decarboxylase as supportive diagnostic biomarkers for Parkinson’s disease

Paslawski W., Khosousi S., Hertz E. et al.

Olink Target 96NeurologyPatient StratificationCSF

Clinical Immunology, 2023
Similarities and differences between myocarditis following COVID-19 mRNA vaccine and multiple inflammatory syndrome with cardiac involvement in children

Amodio D., Pascucci G., Cotugno N. et al.

Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPlasma

Journal of the American Heart Association, 2023
Causal Effects of YKL‐40 on Ischemic Stroke and Its Subtypes: A 2‐Sample Mendelian Randomization Study

Xu Q., Sun L., Wang Y. et al.

Olink Target 96CVDPathophysiologyPlasma

Cell Reports Medicine, 2023
Plasma proteins and onset of type 2 diabetes and diabetic complications: Proteome-wide Mendelian randomization and colocalization analyses

Yuan S., Xu F., Li X. et al.

Olink Explore 3072/384Metabolic DiseasesPathophysiologyPlasma

Vascular Pharmacology, 2023
Circulating soluble IL-6 receptor associates with plaque inflammation but not with atherosclerosis severity and cardiovascular risk

Edsfeldt A., Gonçalves I., Vigren I. et al.

Olink Target 96CVDPathophysiologyPlasma

Science Translational Medicine, 2023
A complement atlas identifies interleukin-6–dependent alternative pathway dysregulation as a key druggable feature of COVID-19

Van Damme K., Hoste L., Declercq J. et al.

Olink Explore 3072/384Infectious DiseasesPathophysiologySerum

Journal for ImmunoTherapy of Cancer, 2023
Antitumor immunity as the basis for durable disease-free treatment-free survival in patients with metastatic urothelial cancer

Anker J., Pal S., Kim-Schulze S. et al.

Olink Target 96OncologyImmunotherapyPathophysiologyPlasma

Liver International, 2023
Binge drinking episode causes acute, specific alterations in systemic and hepatic inflammation‐related markers

Stankevic E., Israelsen M., Juel H. et al.

Olink Target 96HepatologyPathophysiologyPlasma

Journal of Endocrinological Investigation, 2023
Serum biomarkers related to frailty predict negative outcomes in older adults with hip fracture

Cedeno-Veloz B., Lozano-Vicario L., Rodríguez-García A. et al.

Olink Target 48AgingPatient StratificationSerum

Nature Communications, 2023
Genetic analysis of blood molecular phenotypes reveals common properties in the regulatory networks affecting complex traits

Brown A., Fernandez-Tajes J., Hong M. et al.

Olink Target 96Wider Proteomics StudiesPathophysiologyPlasma

Journal of Cancer Research and Clinical Oncology, 2023
Genetically determined circulating resistin concentrations and risk of colorectal cancer: a two-sample Mendelian randomization study

Pham T., Nimptsch K., Papadimitriou N. et al.

Olink Target 96OncologyPathophysiologyPlasma

Aging Cell, 2023
Peripheral inflammatory biomarkers are associated with cognitive function and dementia: Framingham Heart Study Offspring cohort

Chen J., Doyle M., Fang Y. et al.

Olink Target 96NeurologyPathophysiologyPatient StratificationPlasma

Journal of Cerebral Blood Flow & Metabolism, 2023
A cluster of blood-based protein biomarkers associated with decreased cerebral blood flow relates to future cardiovascular events in patients with cardiovascular disease

Overmars L., Kuipers S., van Es B. et al.

Olink Target 96CVDPathophysiologyPlasma

iScience, 2023
Transcriptomic and proteomic assessment of tocilizumab response in a randomized controlled trial of patients hospitalized with COVID-19

Shivram H., Hackney J., Rosenberger C. et al.

Olink Explore 3072/384Infectious DiseasesPathophysiologySerumBlood

Nature Immunology, 2023
Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets

Zhao J., Stacey D., Eriksson N. et al.

Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPlasma

eClinicalMedicine, 2023
Parsaclisib, a PI3Kδ inhibitor, in relapsed and refractory mantle cell lymphoma (CITADEL-205): a phase 2 study

Zinzani P., Trněný M., Ribrag V. et al.

Olink Target 96OncologyPathophysiologyPlasma

Research and Practice in Thrombosis and Haemostasis, 2023
Tranexamic acid in a mouse model of cerebral amyloid angiopathy: setting the stage for a novel stroke treatment approach

Liu Z., McCutcheon F., Ho H. et al.

Olink Target 96CVDNeurologyPathophysiologyPlasma

2798 publications